Get started
Author

Kadondi Kasera

Observed names: K Kasera, K. Kasera, Kasera, K, Kasera, Kadondi
OpenAlex ID: A5011989975
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
2020 · Sophie Uyoga, Ifedayo M.O. Adetifa, et al. · Science · 317
Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya
2018 · Masini Enos, Joseph Sitienei, et al. · PLoS ONE · 137
PDF
Indirect health effects of the COVID-19 pandemic in Kenya: a mixed methods assessment
2021 · Edwine Barasa, Jacob Kazungu, et al. · BMC Health Services Research · 121
PDF
COVID-19 transmission dynamics underlying epidemic waves in Kenya
2021 · Samuel P. C. Brand, John Ojal, et al. · Science · 85
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
2021 · Ifedayo M. O. Adetifa, Sophie Uyoga, et al. · Nature Communications · 64
PDF
Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021
2021 · Sophie Uyoga, Ifedayo M.O. Adetifa, et al. · JAMA · 47
PDF
Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
2021 · George Githinji, Zaydah R. de Laurent, et al. · Nature Communications · 43
PDF
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya
2021 · Anthony O Etyang, Ruth Lucinde, et al. · Clinical Infectious Diseases · 43
PDF
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
2022 · Stacey Orangi, John Ojal, et al. · BMJ Global Health · 42
PDF
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
2022 · R. Lucinde, D. Mugo, et al. · PLoS ONE · 34
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
2021 · E Wangeci Kagucia, John N Gitonga, et al. · Open Forum Infectious Diseases · 31
PDF
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
2021 · John Ojal, Samuel P. C. Brand, et al. · Wellcome Open Research · 31
PDF
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
2022 · Anthony O. Etyang, Ifedayo Adetifa, et al. · PLOS Global Public Health · 28
Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study
2022 · Charles N Agoti, Lynette Isabella Ochola-Oyier, et al. · eLife · 25
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022
2023 · E. Wangeci Kagucia, Abdhala K. Ziraba, et al. · Influenza and Other Respiratory Viruses · 24
PDF
Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
2023 · M. Otiende, A. Nyaguara, et al. · Nature Communications · 19
PDF
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
2022 · John Ojal, Samuel P. C. Brand, et al. · Wellcome Open Research · 18
PDF
Adapting Longstanding Public Health Collaborations between Government of Kenya and CDC Kenya in Response to the COVID-19 Pandemic, 2020–2021
2022 · Amy Herman-Roloff, Rashid Aman, et al. · Emerging infectious diseases · 17
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
2022 · James Nyagwange, Leonard Ndwiga, et al. · Wellcome Open Research · 16
PDF
Characterization of COVID-19 cases in the early phase (March to July 2020) of the pandemic in Kenya
2022 · Philip Ngere, Joyce Onsongo, et al. · Journal of Global Health · 13
PDF
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
2023 · Mainga Hamaluba, Samuel Sang, et al. · Wellcome Open Research · 7
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic
2024 · Ruth Khadembu Lucinde, Henry Gathuri, et al. · BMC Infectious Diseases · 3
PDF
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration
2024 · E. Wangeci Kagucia, Shirine Voller, et al. · Gates Open Research · 3
Effects of the COVID-19 pandemic on hospital admissions and inpatient mortality in Kenya
2022 · M Ogero, L Isaaka, et al. · medRxiv · 3
PDF
What can we learn about everyday health system resilience and pandemic response and preparedness from Kenyan and South African COVID-19 experiences?
2024 · Lucy Gilson, Edwine Barasa, et al. · Edward Elgar Publishing eBooks · 1
Works count: 44
Citation count: 1,192
H-index: 17
I10-index: 20
Year
Topic
Type